Chinese equities have held up remarkably well in the past few weeks, despite a serious COVID outbreak that raises the risk of a lot of disruption to the economy. That might reflect how a lot of bad news already seems to be discounted in China’s stock markets, and we suspect low valuations could limit the scope for Chinese equities to underperform by much more from here.
China Drop-In (29th Nov.): Join our special briefing on the global macro and market consequences of China’s latest zero-COVID lockdowns. Register here.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services